Top

Published in:

01-01-2016 | Original Article

Laparoscopic gastrectomy for remnant gastric cancer: a comprehensive review and case series

Authors: Shigeru Tsunoda, Hiroshi Okabe, Eiji Tanaka, Shigeo Hisamori, Motoko Harigai, Katsuhiro Murakami, Yoshiharu Sakai

Published in: Gastric Cancer | Issue 1/2016

Abstract

Background

Remnant gastric cancer is increasing with the earlier detection of gastric cancer and improved medical care. Laparoscopic gastrectomy for remnant gastric cancer has been reported sporadically in association with the increased use of minimally invasive techniques. However, because of the rarity of remnant gastric cancer, the number of cases reported per study has been small. We therefore reviewed all published English-language reports, including our experience, to better characterize the technical aspects of currently used procedures.

Methods

Ten patients who underwent laparoscopic gastrectomy for remnant cancer between August 2005 and March 2014 were retrospectively studied. A comprehensive literature search was performed using the PubMed database to identify English-language studies on laparoscopic gastrectomy for remnant gastric cancer that were published before May 2014.

Results

There was no conversion to open surgery. The mean operating time was 325 min, and mean intraoperative blood loss was 55 g. The mean number of retrieved lymph nodes was 22, and mean postoperative hospital stay was 13 days. There was only one minor wound infection (overall morbidity rate, 10 %). From the literature review, all comparative studies revealed that laparoscopic gastrectomy for remnant gastric cancer required a longer operating time, and most studies reported less intraoperative blood loss, an equivalent number of harvested lymph nodes, and a shorter postoperative stay as compared with open surgery.

Conclusion

Proficiency in advanced laparoscopic surgical techniques, such as proper adhesiolysis and stable laparoscopic anastomosis, will allow laparoscopic gastrectomy for remnant gastric cancer to be performed with satisfactory short-term results. This minimally invasive approach can be one treatment option for remnant gastric cancer.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer. 2010;127:2893–917.PubMedCrossRef

Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg. 2007;94:92–5.PubMedCrossRef

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions. J Am Coll Surg. 1996;182:1–6.PubMed

Van Cutsem E, Van de Velde C, Roth A, Lordick F, Cascinu S, Aapor M, European Organisation for Research and Treatment of Cancer (EORTC)–Gastrointestinal Cancer Group. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)–Gastrointestinal Cancer Group. Eur J Cancer. 2008;44:182–94.PubMedCrossRef

Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef

Yamada H, Kojima K, Yamashita T, Kawano T, Sugihara K, Nihei Z. Laparoscopy-assisted resection of gastric remnant cancer. Surg Laparosc Endosc Percutaneous Tech. 2005;15:226–9.CrossRef

Kim HS, Kim BS, Lee IS, Lee S, Yook JH. Laparoscopic gastrectomy in patients with previous gastrectomy for gastric cancer: a report of 17 cases. Surg Laparosc Endosc Percutaneous Tech. 2014;24:177–82.CrossRef

Kwon IG, Cho I, Guner A, Choi YY, Shin HB, Kim HI, An JY, Cheong JH, Noh SH, Hyung WJ. Minimally invasive surgery for remnant gastric cancer: a comparison with open surgery. Surg Endosc 2014;28(8):2452–8.

Nagai E, Nakata K, Ohuchida K, Miyasaka Y, Shimizu S, Tanaka M. Laparoscopic total gastrectomy for remnant gastric cancer: feasibility study. Surg Endosc. 2014;28:289–96.PubMedCrossRef

10.

Son SY, Lee CM, Jung DH, Lee JH, Ahn SH, Park do J, Kim HH. Laparoscopic completion total gastrectomy for remnant gastric cancer: a single-institution experience. Gastric Cancer. 2015;18(1):177–82.PubMedCrossRef

11.

UICC International Union Against Cancer. TNM classification of malignant tumours, 7th edn. New York: Wiley; 2009.

12.

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.PubMedPubMedCentralCrossRef

13.

Tsunoda S, Okabe H, Obama K, Tanaka E, Akagami M, Kinjo Y, Sakai Y. Laparoscopic gastrectomy for patients with a history of upper abdominal surgery: results of a matched-pair analysis. Surg Today. 2014;44:271–6.PubMedCrossRef

14.

Obama K, Okabe H, Hosogi H, Tanaka E, Itami A, Sakai Y. Feasibility of laparoscopic gastrectomy with radical lymph node dissection for gastric cancer: from a viewpoint of pancreas-related complications. Surgery 2011;149:15–21.PubMedCrossRef

15.

Okabe H, Obama K, Kan T, Tanaka E, Itami A, Sakai Y. Medial approach for laparoscopic total gastrectomy with splenic lymph node dissection. J Am Coll Surg. 2010;211:e1–6.PubMedCrossRef

16.

Tsunoda S, Okabe H, Obama K, Tanaka E, Hisamori S, Kinjo Y, Sakai Y. Short-term outcomes of totally laparoscopic total gastrectomy: experience with the first consecutive 112 cases. World J Surg 2014;38(10):2662–7.

17.

Okabe H, Tsunoda S, Tanaka E, Hisamori S, Kawada H, Sakai Y. Is laparoscopic total gastrectomy a safe operation? A review of various anastomotic techniques and their outcomes. Surg Today. 2014. doi:10.1007/s00595-014-0901-9.

18.

Okabe H, Obama K, Tanaka E, Nomura A, Kawamura J, Nagayama S, Itami A, Watanabe G, Kanaya S, Sakai Y. Intracorporeal esophagojejunal anastomosis after laparoscopic total gastrectomy for patients with gastric cancer. Surg Endosc. 2009;23:2167–71.PubMedCrossRef

19.

Corcione F, Pirozzi F, Marzano E, Cuccurullo D, Settembre A, Miranda L. Laparoscopic approach to gastric remnant-stump: our initial successful experience on 3 cases. Surg Laparosc Endosc Percutaneous Tech. 2008;18:502–5.CrossRef

20.

Cho HJ, Kim W, Hur H, Jeon HM. Laparoscopy-assisted completion total gastrectomy for gastric cancer in remnant stomach: report of 2 cases. Surg Laparosc Endosc Percutaneous Tech. 2009;19:e57–60.CrossRef

21.

Song J, Kim JY, Kim S, Choi WH, Cheong JH, Hyung WJ, Choi SH, Noh SH. Laparoscopic completion total gastrectomy in remnant gastric cancer: technical detail and experience of two cases. Hepatogastroenterology. 2009;56:1249–52.PubMed

22.

Qian F, Yu PW, Hao YX, Sun GH, Tang B, Shi Y, Lan YL, Luo HX, Mo A. Laparoscopy-assisted resection for gastric stump cancer and gastric stump recurrent cancer: a report of 15 cases. Surg Endosc. 2010;24:3205–9.PubMedCrossRef

23.

Shinohara T, Hanyu N, Tanaka Y, Murakami K, Watanabe A, Yanaga K. Totally laparoscopic complete resection of the remnant stomach for gastric cancer. Langenbecks Arch Surg. 2013;398:341–5.PubMedCrossRef

24.

Kanaya S, Haruta S, Kawamura Y, Yoshimura F, Inaba K, Hiramatsu Y, Ishida Y, Taniguchi K, Isogaki J, Uyama I. Video: Laparoscopy distinctive technique for suprapancreatic lymph node dissection: medial approach for laparoscopic gastric cancer surgery. Surg Endosc. 2011;25:3928–9.PubMedCrossRef

25.

Curet MJ. Special problems in laparoscopic surgery. Previous abdominal surgery, obesity, and pregnancy. Surg Clin N Am. 2000;80:1093–110.PubMedCrossRef

26.

Tokunaga M, Hiki N, Fukunaga T, Nunobe S, Ohyama S, Yamaguchi T. Laparoscopy-assisted gastrectomy for patients with earlier upper abdominal open surgery. Surg Laparosc Endosc Percutaneous Tech. 2010;20:16–9.CrossRef

27.

Okabe H, Obama K, Tsunoda S, Tanaka E, Sakai Y. Advantage of completely laparoscopic gastrectomy with linear stapled reconstruction: a long-term follow-up study. Ann Surg. 2014;259:109–16.PubMedCrossRef

28.

Inaba K, Satoh S, Ishida Y, Taniguchi K, Isogaki J, Kanaya S, Uyama I. Overlap method: novel intracorporeal esophagojejunostomy after laparoscopic total gastrectomy. J Am Coll Surg. 2010;211:e25–9.PubMedCrossRef

29.

Viñuela EF, Gonen M, Brennan MF, Coit DG, Strong VE. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg. 2012;255:446–56.PubMedCrossRef

30.

Cheng Q, Pang TC, Hollands MJ, Richardson AJ, Pleass H, Johnston ES, Lam VW. Systematic review and meta-analysis of laparoscopic versus open distal gastrectomy. J Gastrointest Surg. 2014;18:1087–99.PubMedCrossRef

31.

Xiong JJ, Nunes QM, Huang W, Tan CL, Ke NW, Xie SM, Ran X, Zhang H, Chen YH, Liu XB. Laparoscopic vs. open total gastrectomy for gastric cancer: a meta-analysis. World J Gastroenterol. 2013;19:8114–32.PubMedPubMedCentralCrossRef

Title: Laparoscopic gastrectomy for remnant gastric cancer: a comprehensive review and case series
Authors: Shigeru Tsunoda
Hiroshi Okabe
Eiji Tanaka
Shigeo Hisamori
Motoko Harigai
Katsuhiro Murakami
Yoshiharu Sakai
Publication date: 01-01-2016
Publisher: Springer Japan
Published in: Gastric Cancer / Issue 1/2016
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI: https://doi.org/10.1007/s10120-014-0451-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Skip lymph node metastasis in gastric cancer: is it skipping or skipped?

C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection

Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?

A Hercule Poirot of clinical research

Partially covered self-expandable metallic stent for postoperative benign strictures associated with laparoscopy-assisted gastrectomy

Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials